Shaanxi Meibang Pharmaceutical Group Co Ltd Market Cap ($338.11 Million)
Market Cap & Net Worth: Shaanxi Meibang Pharmaceutical Group Co Ltd (605033)
Shaanxi Meibang Pharmaceutical Group Co Ltd market cap. Shaanxi Meibang Pharmaceutical Group Co Ltd (SHG:605033) has a market capitalization of $338.11 Million (CN¥2.31 Billion) as of November 9, 2026. Listed on the SHG stock exchange, this China-based company holds position #13942 globally and #4139 in its home market, demonstrating a -0.06% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shaanxi Meibang Pharmaceutical Group Co Ltd's stock price CN¥17.09 by its total outstanding shares 135200000 (135.20 Million). Also see cash flow conversion of Shaanxi Meibang Pharmaceutical Group Co for how efficiently the company converts equity into cash flow.
Shaanxi Meibang Pharmaceutical Group Co Ltd Market Cap History (2021–2026)
Shaanxi Meibang Pharmaceutical Group Co Ltd market cap history from 2021 to 2026. Data shows change from $511.91 Million to $338.11 Million (-0.68% CAGR). Check current stock price of Shaanxi Meibang Pharmaceutical Group Co for real-time trading data and today's change.
Shaanxi Meibang Pharmaceutical Group Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shaanxi Meibang Pharmaceutical Group Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset growth rate of Shaanxi Meibang Pharmaceutical Group Co to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.27x
Shaanxi Meibang Pharmaceutical Group Co Ltd's market cap is 0.27 times its annual revenue
Latest Price to Earnings (P/E) Ratio
6.46x
Shaanxi Meibang Pharmaceutical Group Co Ltd's market cap is 6.46 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $511.91 Million | $842.49 Million | $125.74 Million | 0.61x | 4.07x |
| 2022 | $330.48 Million | $906.05 Million | $145.09 Million | 0.36x | 2.28x |
| 2023 | $350.81 Million | $699.03 Million | $57.56 Million | 0.50x | 6.09x |
| 2024 | $238.00 Million | $885.53 Million | $36.86 Million | 0.27x | 6.46x |
Competitor Companies of 605033 by Market Capitalization
Companies near Shaanxi Meibang Pharmaceutical Group Co Ltd in the global market cap rankings as of November 9, 2026. Also see 605033 current and non-current assets for a full breakdown of the balance sheet.
Key companies related to Shaanxi Meibang Pharmaceutical Group Co Ltd by market ranking:
- Nutrien Ltd (TO:NTR): Ranked #759 globally with a market cap of $34.82 Billion USD ( CA$48.13 Billion CAD).
- Qinghai Salt Lake Industry Co.Ltd (SHE:000792): Ranked #1368 globally with a market cap of $17.93 Billion USD ( CN¥122.50 Billion CNY).
- CF Industries Holdings Inc (NYSE:CF): Ranked #1449 globally with a market cap of $16.81 Billion USD.
- Yara International ASA (OL:YAR): Ranked #2054 globally with a market cap of $10.75 Billion USD ( Nkr102.12 Billion NOK).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #759 | Nutrien Ltd | TO:NTR | $34.82 Billion | CA$100.86 |
| #1368 | Qinghai Salt Lake Industry Co.Ltd | SHE:000792 | $17.93 Billion | CN¥23.15 |
| #1449 | CF Industries Holdings Inc | NYSE:CF | $16.81 Billion | $119.39 |
| #2054 | Yara International ASA | OL:YAR | $10.75 Billion | Nkr401.00 |
Market Capitalization of Shaanxi Meibang Pharmaceutical Group Co Ltd (2021–2026)
Market capitalization of Shaanxi Meibang Pharmaceutical Group Co Ltd from 2021 to today. Between 2021 and today, Shaanxi Meibang Pharmaceutical Group Co Ltd's market cap moved from $511.91 Million to $ 338.11 Million, with a yearly change of -0.68%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥338.11 Million | -14.89% |
| 2025 | CN¥397.26 Million | +66.92% |
| 2024 | CN¥238.00 Million | -32.16% |
| 2023 | CN¥350.81 Million | +6.15% |
| 2022 | CN¥330.48 Million | -35.44% |
| 2021 | CN¥511.91 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 9th, 2026 the market cap of Shaanxi Meibang Pharmaceutical Group Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $338.11 Million USD |
| MoneyControl | $338.11 Million USD |
| MarketWatch | $338.11 Million USD |
| marketcap.company | $338.11 Million USD |
| Reuters | $338.11 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Shaanxi Meibang Pharmaceutical Group Co Ltd
Shaanxi Meibang Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research and development, production, sale, and agricultural technology promotion, and service of pesticide products in China and internationally. The company offers pesticides, fungicides, herbicides, plant growth regulators, fertilizers, and microbial fertilizers. It is also involved in sale of agricu… Read more